Breaking News

Almac Expands Formulation Development Services

Opens non-GMP facility and two analytical labs at UK headquarters

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac has expanded its pharmaceutical development service offering with an investment of more than $10 million. The company has doubled its development service capabilities with the opening of a new dedicated non-GMP facility and two analytical laboratories at its UK headquarters.    The new non-GMP formulation development facility offers formulation and process development, which can then be progressed and transferred to the existing GMP development facility located on the same campus. Almac ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters